Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Finasteride and minoxidil work best together for hair loss.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Stem cell therapy is a promising approach for hair regrowth despite potential side effects.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.